cliexa Raises $3.33M in Latest Round to Expand AI Clinical Intelligence Platform for Healthcare Systems
cliexa, a Denver-based healthcare AI company building a clinical intelligence platform that connects patient data, clinical workflows, and revenue cycle systems, has raised approximately $9.1 million in total funding as it continues expanding its AI-driven infrastructure for healthcare providers, payers, and life sciences organizations.
The company’s most recent financing includes a $3.33 million funding round completed in 2026, contributing to its continued growth as it scales its enterprise healthcare AI platform across clinical, operational, and billing workflows. The round reflects ongoing investor interest in healthcare infrastructure companies that use artificial intelligence to streamline care delivery and administrative processes.
Earlier, cliexa secured seed-stage funding of around $544,000 in 2017, backed by early angel investors including Mehmet Kazgan, Haluk Yilmazturk, and accelerator participation through Boomtown Accelerators, which supported the company during its initial product development phase focused on smart patient intake and EMR integration systems.
The company also benefited from strategic institutional partnerships that helped shape its technology and validation pathway. Notably, cliexa has worked with and received investment support from the American College of Cardiology, which contributed to the development of proprietary cardiovascular monitoring algorithms and population health models. In later stages, the company further validated its platform through collaborations with the Mayo Clinic Platform, which also supported its machine learning training efforts using large-scale de-identified patient datasets.
cliexa builds an AI-powered clinical intelligence system designed to act as a “reasoning layer” across healthcare workflows. The platform integrates with existing electronic medical records (EMR) systems and focuses on transforming fragmented healthcare data into structured, actionable insights for clinicians, billers, and administrators.
At its core is cliexaAI, a proprietary clinical rules engine that combines machine learning with clinical decision logic to support patient care, compliance, and revenue cycle optimization. The system is designed to assist with tasks such as clinical documentation, diagnostic recommendations, billing accuracy, surgical scheduling, and denial prevention, while continuously learning from patient and provider feedback.
The company positions its technology as an interoperability and intelligence layer rather than a replacement for existing healthcare systems. Instead of rebuilding electronic health records, cliexa integrates across them, enabling real-time clinical reasoning across multiple points in the care journey—from patient intake to post-treatment follow-up.
Founded in 2016 by CEO Mehmet Kazgan, cliexa emerged from early efforts to improve EMR-based patient data capture and evolved into a broader AI healthcare platform supporting enterprise-scale deployments. The leadership team includes clinicians, engineers, and healthcare operations experts focused on aligning clinical outcomes with financial and operational efficiency.
According to publicly available company data, cliexa has processed large-scale clinical datasets and supports deployments in areas such as cardiovascular care, chronic disease management, and pain management workflows. Its system is also used for predictive risk modeling, automated documentation, and payer-aligned decision support.
Investor interest in cliexa reflects broader momentum in healthcare AI, particularly platforms that reduce administrative burden while improving clinical accuracy and reimbursement efficiency. The company’s combination of clinical validation, payer alignment, and enterprise integration has positioned it within a growing category of “clinical intelligence infrastructure” startups.
With its latest funding, cliexa plans to expand its AI capabilities, deepen integration across healthcare systems, and scale adoption among hospitals, specialty practices, and life sciences organizations, reinforcing its goal of becoming a foundational intelligence layer for modern healthcare operations.
